These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8868042

  • 1. Hypertension can be treated effectively without increasing the cost of care.
    Moser M.
    J Hum Hypertens; 1996 Feb; 10 Suppl 2():533-8. PubMed ID: 8868042
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?
    Lorgelly P, Siatis I, Brooks A, Slinn B, Millar-Craig MW, Donnelly R, Manning G.
    Br J Gen Pract; 2003 Oct; 53(495):794-6. PubMed ID: 14601356
    [Abstract] [Full Text] [Related]

  • 6. Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial.
    Madsen LB, Christiansen T, Kirkegaard P, Pedersen EB.
    Blood Press; 2011 Apr; 20(2):117-25. PubMed ID: 21105759
    [Abstract] [Full Text] [Related]

  • 7. The costs of treating hypertension: what are the long-term realities of cost containment and pharmacoeconomics?
    Elliott WJ.
    Postgrad Med; 1996 Apr; 99(4):241-8, 251-2. PubMed ID: 8604411
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Linjer E, Hedner T, Jönsson B, Ekbom T, Lindholm LH, Dahlöf B, de Faire U, Scherstén B, Stop-2 Hypertension Group.
    Blood Press; 2005 Apr; 14(2):107-13. PubMed ID: 16036488
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Compliance with antihypertensive therapy: raising the bar of expectations.
    Rudd P.
    Am J Manag Care; 1998 Jul; 4(7):957-66. PubMed ID: 10181995
    [Abstract] [Full Text] [Related]

  • 12. The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension.
    Funahashi J, Ohkubo T, Fukunaga H, Kikuya M, Takada N, Asayama K, Metoki H, Obara T, Inoue R, Hashimoto J, Totsune K, Kobayashi M, Imai Y.
    Blood Press Monit; 2006 Oct; 11(5):257-67. PubMed ID: 16932035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beware the Medical-Industrial Complex.
    Stevens CW, Glatstein E.
    Oncologist; 1996 Oct; 1(4):IV-V. PubMed ID: 10388005
    [Abstract] [Full Text] [Related]

  • 18. Pharmacoeconomic challenges in disease management of hypertension.
    Ambrosioni E.
    J Hypertens Suppl; 2001 Sep; 19(3):S33-40. PubMed ID: 11713849
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Medical and cost-economy aspects of modern antihypertensive therapy--with special reference to 2 years of clinical experience with losartan.
    Hansson L.
    Blood Press Suppl; 1997 Sep; 1():52-5. PubMed ID: 9285110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.